Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology cash
Cash and short-term investments held at the end of each period.
Regenerative Medical Technology's cash was $1.32M at Jun 30, 2026. For fiscal 2025 it was $956.72K, down 17.9% from the year before. The highest annual figure on record is $2.98M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $956.72K | -17.9% |
| FY2024 | Dec 31, 2024 | $1.17M | +119.7% |
| FY2023 | Dec 31, 2023 | $530.54K | -67.8% |
| FY2022 | Dec 31, 2022 | $1.65M | -44.8% |
| FY2021 | Dec 31, 2021 | $2.98M | +6902.7% |
| FY2020 | Dec 31, 2020 | $42.53K | +81.9% |
| FY2019 | Dec 31, 2019 | $23.38K | -24.2% |
| FY2018 | Dec 31, 2018 | $30.83K | +297.9% |
| FY2017 | Dec 31, 2017 | $7.75K | +16.6% |
| FY2016 | Dec 31, 2016 | $6.65K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.32M | -18.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.06M | -13.2% |
| Q4 FY2025 | Dec 31, 2025 | $956.72K | -17.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.19M | +41.8% |
| Q2 FY2025 | Jun 30, 2025 | $1.61M | +161.6% |
| Q1 FY2025 | Mar 31, 2025 | $1.22M | +111.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.17M | +119.7% |
| Q3 FY2024 | Sep 30, 2024 | $836.43K | -26.9% |
| Q2 FY2024 | Jun 30, 2024 | $617.09K | -49.6% |
| Q1 FY2024 | Mar 31, 2024 | $579.35K | -64.6% |
| Q4 FY2023 | Dec 31, 2023 | $530.54K | -67.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.14M | -35.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.23M | -36.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.64M | -33.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.65M | -44.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.77M | -83.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.92M | -81.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.46M | +212.4% |
| Q4 FY2021 | Dec 31, 2021 | $2.98M | +6902.7% |
| Q3 FY2021 | Sep 30, 2021 | $10.73M | +17939.9% |
| Q2 FY2021 | Jun 30, 2021 | $10.49M | +90602.4% |
| Q1 FY2021 | Mar 31, 2021 | $787.67K | +6822.2% |
| Q4 FY2020 | Dec 31, 2020 | $42.53K | +81.9% |
| Q3 FY2020 | Sep 30, 2020 | $59.47K | +212303.6% |
| Q2 FY2020 | Jun 30, 2020 | $11.57K | -71.2% |
| Q1 FY2020 | Mar 31, 2020 | $11.38K | +1868.7% |
| Q4 FY2019 | Dec 31, 2019 | $23.38K | -24.2% |
| Q3 FY2019 | Sep 30, 2019 | $28 | -99.9% |
| Q2 FY2019 | Jun 30, 2019 | $40.15K | +55.8% |
| Q1 FY2019 | Mar 31, 2019 | $578 | -92.5% |
| Q4 FY2018 | Dec 31, 2018 | $30.83K | +363.8% |
| Q3 FY2018 | Sep 30, 2018 | $30.31K | – |
| Q2 FY2018 | Jun 30, 2018 | $25.77K | – |
| Q4 FY2017 | Dec 31, 2017 | $7.75K | – |
| Q4 FY2016 | Dec 31, 2016 | $6.65K | – |
See a number that looks wrong?